Blood-based tumor mutation burden: continued progress toward personalizing immunotherapy in non-small cell lung cancer
J Thorac Dis
.
2019 Jun;11(6):2208-2211.
doi: 10.21037/jtd.2019.05.68.
Authors
Vincent K Lam
1
,
Jianjun Zhang
1
Affiliation
1
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
PMID:
31372254
PMCID:
PMC6626794
DOI:
10.21037/jtd.2019.05.68
No abstract available
Publication types
Editorial
Comment
Grants and funding
R01 CA234629/CA/NCI NIH HHS/United States